RadNet (RDNT) Could Be 27% Undervalued As AI Growth Drives The Bull Case
RadNet (RDNT) has drawn investor attention after recent trading left the share price at US$67.70, with performance down over the past month and past 3 months, despite strong multi-year total return figures.
Recent trading has cooled momentum in RadNet, with the share price down 5.1% over the past week and 10.4% over the past month. However, the 3 year total shareholder return of 135.9% and 5 year total shareholder return of 134.6% still indicate a strong longer term outcome.
Scan beyond RadNet and compare it with a hand picked group of healthcare AI peers using the 35 healthcare AI stocks as a starting point for your research.
Bulls point to RadNet's long term total returns and push into AI health informatics, while bears highlight the recent share price pullback and current loss making status. Which story does the valuation actually support?
Most Popular Narrative: 27% Undervalued
Against a last close of $67.70, the most followed narrative pegs RadNet's fair value at $92.88, which frames the current pullback as a pricing gap rather than a verdict on the business.
Ongoing investments in AI-powered imaging solutions (e.g., DeepHealth, See-Mode, iCAD) are materially increasing center throughput, boosting capacity utilization, and driving more high-margin advanced procedures, directly enhancing both revenue growth and EBITDA margins.
See why 8 investors see RadNet as 27% undervalued.
Result: Fair Value of $92.88 (UNDERVALUED)
Still, heavy spending on AI and digital health, alongside the planned US$200 million term loan, could pressure cash generation if reimbursement terms or imaging demand disappoint.
Find out about the key risks to this RadNet narrative.
Another View: RadNet Through A Sales Multiple Lens
The SWS fair value work paints RadNet as undervalued, yet the price tag looks different when you zoom in on sales. At a P/S of 2.3x, the stock trades well above the US Healthcare sector on 1.3x and the fair ratio of 1.1x, which signals real multiple risk if sentiment cools.
That kind of gap can close in two ways: either fundamentals eventually justify paying more per dollar of revenue, or the share price does more of the adjusting.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Sentiment on RadNet is clearly split, with strong long term returns on one side and valuation and balance sheet questions on the other. Move quickly, dig into the details yourself, and weigh the 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond RadNet?
If RadNet has your attention but you want a wider watchlist, use the Simply Wall Street Screener to quickly surface fresh ideas that match your style.
- Target underpriced opportunities by running the 28 high quality undervalued stocks and see which companies the market may be overlooking right now.
- Prioritize resilience and aim to sleep better at night by filtering for 31 resilient stocks with low risk scores to balance upside with more controlled downside.
- Look for potential opportunities by scanning for 19 high quality undiscovered gems before they appear on more investors' radars.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com